Effects of the second comparative study have been noted by Flinn et al. This can be a section III randomized Intergroup trial comparing FC regimen compared to FAMP by yourself in 278 people acquiring their initial chemotherapy regimen for B-CLL. Dosages of FC agenda had been the same as the https://friedrichi544sdo6.azuria-wiki.com/user